Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2010-12-15 12:28:46 Antibiotics Beta-lactam antibiotics Streptococcaceae Phenoxymethylpenicillin Penicillin Streptococcus Antibiotic resistance Enterococcus Antibacterial Bacteria Microbiology Gram-positive bacteria		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 160,61 KB Share Document on Facebook

	CCLG - AfterCure - Splenectomy - ‘Having No Spleen’ DocID: 18CxU - View Document
	AFTER HOURS PLUS MEDICATIONS – INFORMATION SHEETS *While the ‘active ingredient’ of medications provided to After Hours Plus members is consistent, the brand may vary depending on location. If the brand provided by DocID: 11q0k - View Document
	LPV™ Phenoxymethylpenicillin (as potassium) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LPV. It does not contain all the available DocID: 10Spn - View Document
	Phenoxymethylpenicillin-AFT Powder for Oral Liquid BP, Phenoxymethylpenicillin potassium equivalent to Phenoxymethylpenicillin 125 mg/5 mL and 250 mg/5 mL Consumer Medicine Information What is in this leaflet This leafle DocID: 10qRk - View Document
	HF-dotted-indig-Heart-Grey DocID: VcUk - View Document